• Home
• About Us
• About Us Home
• Jeff George

Jeff George

Global Head of Sandoz
Novartis Executive Committee member

Jeff George has led Sandoz since October 2008.  Sandoz is the world’s second-largest generic pharmaceutical company globally with 2010 sales of USD 8.5 billion.  Sandoz employs over 24,000 people in more than 130 countries, and its product price points are accessible to nearly 90% of the world’s population. Sandoz is a global leader in differentiated generics such as injectables and is the pioneer and #1 global player in the emerging field of biosimilars, or “follow on biologics”.

Prior to assuming his current position, Jeff was Head of Emerging Markets for the Middle East, Africa, Southeast Asia and the CIS countries for Novartis Pharma, where he led a team of over 3,000 people across more than 65 markets.  Jeff joined Novartis in January 2007 as Head of Western & Eastern Europe for Novartis Vaccines, where he was responsible for 25 markets from the UK to Russia.

Before joining Novartis, Jeff was Senior Director of Strategic Planning and Business Development at Gap Inc.  Prior to this, he was an Engagement Manager at McKinsey & Company and has also worked in emerging markets private equity in South Africa and the US.

Jeff holds an MBA from Harvard University and a Masters from Johns Hopkins University’s School of Advanced International Studies (SAIS). He also holds a BA in international relations from Carleton College.

Jeff is married and has one daughter. He enjoys playing soccer, running, reading, live music, and international affairs.